false

Katie McGuire

Seasoned pharma leader with extensive expertise in oncology drug development and early phase clinical development. Veteran across multiple therapeutic indications in a wide range of multi-country, full-service studies through every phase. Strong communicator and trained executive coach who thrives on change and excels under pressure.

• Read: Precision for Medicine Re-approved as a CIR-Eligible R&D Partner Under the French Research Tax Credit Programme

  Precision for Medicine Re-approved as a CIR-Eligible R&D Partner Under the French Research Tax Credit Programme

  Oct 21, ‘26 | 2 min read

  • 

    Angelique Heckmann, PhD

  Discover
• Read: The Cells Don't Have to Be Alive: Immunophenotyping post CAR-T Therapy

  The Cells Don't Have to Be Alive: Immunophenotyping post CAR-T Therapy

  Oct 20, ‘26 | 4 min read

  • 

    Sven Olek, PhD

  Discover
• Read: Why In-Country Project Management Is a Non-Negotiable in APAC Trials

  Clinical Trials

  Why In-Country Project Management Is a Non-Negotiable in APAC Trials

  Oct 19, ‘26 | 7 min read

  • 

    Hannah Urbanski

  Discover
• Read: The Operational Reality of Clinical Trial Technology

  Clinical Trials

  The Operational Reality of Clinical Trial Technology

  Oct 12, ‘26 | 8 min read

  • 

  • Sadie O.

    Jennifer W.

  Discover
• Read: Case Study: FIH Radiopharmaceutical Trial Across South Korea and US

  Oncology

  Case Study: FIH Radiopharmaceutical Trial Across South Korea and US

  Oct 05, ‘26 | 7 min read

  • 

    Tai Bibbs

  Discover
• Read: Case Study: Global Phase 2 Drug Delivery in Advanced Colorectal Cancer

  Oncology

  Case Study: Global Phase 2 Drug Delivery in Advanced Colorectal Cancer

  Sep 28, ‘26 | 9 min read

  • 

    Tai Bibbs

  Discover
• Read: Case Study: Managing Complexity in an Autologous Cell Therapy Trial

  Clinical Trials

  Case Study: Managing Complexity in an Autologous Cell Therapy Trial

  Sep 22, ‘26 | 8 min read

  • 

  • Deborah S.

    Saoussen B.

    Jack S.

  Discover
• Read: How Investigator Engagement Builds Enrollment Momentum

  Clinical Trials

  How Investigator Engagement Builds Enrollment Momentum

  Sep 21, ‘26 | 6 min read

  • 

    Lisa Lopez

  Discover
• Read: Case Study: Nectin 4 Biomarker Testing for Oncology Clinical Programs

  Translational Research

  Case Study: Nectin 4 Biomarker Testing for Oncology Clinical Programs

  Sep 14, ‘26 | 3 min read

  • 

    Christie Bongel

  Discover

Loading...

You've reach the end Back to top